We are live on ! Find out more
New York State Common Retirement Fund

New York State Common Retirement Fund Portfolio holdings

AUM $79.3B
1-Year Est. Return 43.63%
This Fund
S&P 500
This Quarter Est. Return
+7.07%
1 Year Est. Return
+43.63%
3 Year Est. Return
+132.82%
5 Year Est. Return
+173.87%
10 Year Est. Return
+697.67%
AUM
$83.1B
AUM Growth
+$4.87B
Cap. Flow
+$134M
Cap. Flow %
0.16%
Top 10 Hldgs %
16.21%
Holding
3,147
New
46
Increased
1,058
Reduced
844
Closed
65

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$52.1M
2
CERN
Cerner Corp
CERN
+$36.1M
3
LVLT
Level 3 Communications Inc
LVLT
+$35.7M
4
PYPL icon
PayPal
PYPL
+$33.3M
5
CNC icon
Centene
CNC
+$31.8M

Sector Composition

Rank Sector Weight
1 Technology 17.19%
2 Financials 16.85%
3 Healthcare 13.78%
4 Industrials 10.8%
5 Consumer Discretionary 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LBY
2851
DELISTED
Libbey, Inc.
LBY
$159K ﹤0.01%
21,200
LXU icon
2852
LSB Industries
LXU
$693M
$158K ﹤0.01%
23,400
MGNI icon
2853
Magnite
MGNI
$3.55B
$158K ﹤0.01%
84,354
-8,703
-9% -$21.8K
ARAV
2854
DELISTED
Aravive, Inc. Common Stock
ARAV
$158K ﹤0.01%
11,936
PZN
2855
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$158K ﹤0.01%
14,800
+3,400
+30% +$38.1K
ESTE
2856
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$158K ﹤0.01%
14,900
+8,500
+133% +$80K
AMRC icon
2857
Ameresco
AMRC
$1.36B
$157K ﹤0.01%
18,300
EML icon
2858
Eastern Company
EML
$150M
$157K ﹤0.01%
6,000
MACK
2859
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$157K ﹤0.01%
19,436
VATE icon
2860
INNOVATE Corp
VATE
$165M
$156K ﹤0.01%
2,620
YEXT icon
2861
Yext
YEXT
$574M
$156K ﹤0.01%
13,000
LAYN
2862
DELISTED
Layne Christensen Co
LAYN
$156K ﹤0.01%
12,400
CLSD
2863
DELISTED
Clearside Biomedical
CLSD
$155K ﹤0.01%
1,473
LAB icon
2864
Standard BioTools
LAB
$314M
$155K ﹤0.01%
26,300
NERV icon
2865
Minerva Neurosciences
NERV
$199M
$155K ﹤0.01%
3,200
SND icon
2866
Smart Sand
SND
$194M
$155K ﹤0.01%
17,900
+5,900
+49% +$45.8K
ARA
2867
DELISTED
American Renal Associates Holdings, Inc
ARA
$155K ﹤0.01%
8,900
EPM icon
2868
Evolution Petroleum
EPM
$131M
$154K ﹤0.01%
22,500
ZYNE
2869
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$153K ﹤0.01%
12,200
PBIP
2870
DELISTED
Prudential Bancorp, Inc.
PBIP
$153K ﹤0.01%
8,700
PETX
2871
DELISTED
Aratana Therapeutics, Inc.
PETX
$153K ﹤0.01%
29,100
KVHI icon
2872
KVH Industries
KVHI
$157M
$152K ﹤0.01%
14,700
PEBK icon
2873
Peoples Bancorp of North Carolina
PEBK
$229M
$152K ﹤0.01%
4,950
UBFO
2874
DELISTED
United Security Bancshares
UBFO
$152K ﹤0.01%
13,800
TLYS icon
2875
Tilly's
TLYS
$128M
$151K ﹤0.01%
10,200

Similar funds

New York State Common Retirement Fund's Q4 2017 Portfolio in Review

As of Q4 2017, New York State Common Retirement Fund held 3,147 positions worth $83.1B, up 6.2% from $78.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2017: portfolio turnover was 3.5%. New York State Common Retirement Fund opened 46 new positions and exited 65, leaving the 3,147-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • New York State Common Retirement Fund's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 431,476 shares worth $22.6M.
  • New York State Common Retirement Fund added most to Henry Schein in Q4 2017, an estimated $66.6M increase.
  • New York State Common Retirement Fund's biggest Q4 2017 reduction was Cerner Corp, cutting an estimated $36.1M.
  • New York State Common Retirement Fund fully exited CR Bard Inc. in Q4 2017, selling an estimated $52.1M.
  • New York State Common Retirement Fund's ten largest holdings make up 16% of its $83.1B portfolio in Q4 2017.
  • New York State Common Retirement Fund opened 46 new positions and closed 65 in Q4 2017.
  • New York State Common Retirement Fund's portfolio value rose 6.2% quarter-over-quarter to $83.1B.

Based on New York State Common Retirement Fund's 13F filing for Q4 2017, filed 13 Feb 2018.